The CDTI Innovation seeks a spanish company specialized in pharmaceutical biotechnology or to work with India in the development of vectors lentivirales
The biotechnology company india Aurigene Oncology, devoted to the discovery and development of innovative and effective therapies for the treatment of cancer, requested the collaboration of a spanish company specialized in the field of biotechnology or pharmacy to develop means of delivery lentivirales. This cooperation also extends to companies interested in the development of new products of gene therapy and cellular
Aurigene Oncology has extensive experience in the development of cutting-edge oncological, with a focus on improving the quality of life of oncological patients.
11Th Llamada España-india joint
The draft international technological collaboration that will be carried out between Aurigene Oncology and the spanish company could be submitted to the11Th Called España-india Multisectoral, in force at the India Spain Innovation Program (ISIP), which until20 may 2025.
In thislinkyou can get more information on this quest.
For more information please refer to:india@cdti.es.
CDTI Innovation
The CDTI Innovation is the agency for financing innovation of the ministry of science, innovation and universities that promotes innovation and technological development of spanish companies, channeling requests for funding and support for r & D & I projects of spanish entities at the state and international levels. We Contribute to the improvement of the technological level of spanish companies and drive and, with an international network with coverage of 51 countries support the spanish participation in international programmes for technology cooperation and the international transfer of technology. The CDTI also supports the creation and consolidation of technology-based enterprises in Spain.
The centre for technological development and innovation, E.P.E. (CDTI) is a public entity under the ministry of Science, innovation and universities.
More information:
Office of the press
prensa@cdti.es
91-581.55.00
On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial
This content is copyright © 2025 CDTI, Soes. Permitted for use and reproduction by quoting the source and digital identity of CDTI (@CDTI _ innovation).